Related Experiment Video

Updated: Aug 11, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Issues in the management of bacterial meningitis

A R Tunkel1, W M Scheld

  • 1Allegheny University of the Health Sciences, Philadelphia, Pennsylvania, USA.

American Family Physician
|October 24, 1997
PubMed

Insights

Emerging antibiotic resistance in bacterial meningitis necessitates updated empiric treatment strategies. Vancomycin plus a third-generation cephalosporin is recommended for Streptococcus pneumoniae meningitis, while dexamethasone aids in Haemophilus influenzae type b meningitis management.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Acute bacterial meningitis presents significant morbidity and mortality challenges.
  • The rise of antibiotic-resistant bacterial strains, particularly Streptococcus pneumoniae, complicates treatment.
  • Current effective antimicrobial therapies require adaptation due to resistance patterns.

Purpose of the Study:

  • To outline updated empiric antimicrobial therapy strategies for bacterial meningitis.
  • To address the challenges posed by antibiotic-resistant pathogens.
  • To provide guidance on adjunctive therapies for specific meningitis types.

Main Methods:

  • Review of current antimicrobial susceptibility data for common meningitis pathogens.
  • Analysis of treatment guidelines for bacterial meningitis.
  • Evaluation of the role of adjunctive therapies in reducing sequelae.

Main Results:

  • Empiric therapy for Streptococcus pneumoniae meningitis now includes vancomycin plus a third-generation cephalosporin.
  • Third-generation cephalosporins remain effective for most community-acquired bacterial meningitis pathogens, excluding Listeria monocytogenes.
  • Ampicillin or penicillin G is the preferred treatment for Listeria monocytogenes meningitis.
  • Adjunctive dexamethasone is recommended for Haemophilus influenzae type b meningitis to mitigate neurologic and audiologic complications.

Conclusions:

  • Updated empiric treatment regimens are crucial for managing bacterial meningitis in the face of antibiotic resistance.
  • Tailored antimicrobial choices are necessary based on pathogen susceptibility.
  • Early administration of dexamethasone with antimicrobial agents improves outcomes for Haemophilus influenzae type b meningitis.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

Published on: July 14, 2020

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...